• SENSEX
    NIFTY 50
Home Market Stocks
Market

Aurobindo Pharma surges over 18% on receiving EIR from USFDA

Updated : February 19, 2020 11:46 AM IST

At 11:42 am, Aurobindo Pharma was trading 18.57 percent higher at Rs 593.10 per share.
Aurobindo Pharma surges over 18% on receiving EIR from USFDA

Special Offer: Subscribe to Moneycontrol PRO at ₹1 per day for the first year. Coupon code: PRO365. Offer available on desktop & android only. *T&C Apply

You May Also Like

Wipro Q1 profit marginally up at Rs 2,390 crore

Wipro Q1 profit marginally up at Rs 2,390 crore

Flipkart raises $1.2 billion at $24.9 billion valuation from Walmart, other existing investors

Flipkart raises $1.2 billion at $24.9 billion valuation from Walmart, other existing investors

Mindtree's travel, hospitality revenues plunge 50%, expects Q2 to be better

Mindtree's travel, hospitality revenues plunge 50%, expects Q2 to be better

Trending on CNBC-TV18

Live TV
Advertisement